The controversial link between antidepressants and suicidality risks in adults: Data from a naturalistic study on a large sample of in-patients with a major depressive episode

International Journal of Neuropsychopharmacology

Volumn 12, Issue 2, 2009, Pages 181-189

  Seemüller, Florian ^a   Riedel, Michael ^a   Obermeier, Michael ^a   Bauer, Michael ^b   Adli, Mazda ^c   Mundt, Christoph ^d   Holsboer, Florian ^e   Brieger, Peter ^f   Laux, Gerd ^g   Bender, Wolfram ^h   Heuser, Isabella ^c   Zeiler, Joachim ⁱ   Gaebel, Wolfgang ^j   Jger, Markus ^a   Henkel, Verena ^a   Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^g Inn Salzach Klinikum   (Germany)

^h KLINIKUM MÜNCHEN OST   (Germany)

ⁱ Vivantes Auguste Viktoria Klinikum   (Germany)

^j University of Dsseldorf   (Germany)

more..

Author keywords

Depression; HAMD item 3; Suicidal ideation; Suicide

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BROMAZEPAM; CITALOPRAM; DIAZEPAM; DOXEPIN; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; OXAZEPAM; PAROXETINE; REBOXETINE; SERTRALINE; TRANQUILIZER; TRANYLCYPROMINE; TRIMIPRAMINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; FOOD AND DRUG ADMINISTRATION; GERMANY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MENTAL HOSPITAL; METHODOLOGY; MULTICENTER STUDY; NURSING STAFF; PERSONALITY DISORDER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIST; PSYCHOTHERAPY; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR; SAMPLE; SCORING SYSTEM; SUICIDAL IDEATION; SUICIDE ATTEMPT; UNITED STATES; UNIVERSITY HOSPITAL; ADOLESCENT; AGE; META ANALYSIS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; STATISTICS; SUICIDE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; GERMANY; HUMANS; LOGISTIC MODELS; META-ANALYSIS AS TOPIC; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SUICIDE; YOUNG ADULT;

EID: 67049143798     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009139     Document Type: Article

References (36)

1. Acharya N, Rosen AS, Polzer JP, D'Souza DN, Perahia DG, Cavazzoni PA, Baldessarini RJ (2006). Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. Journal of Clinical Psychopharmacology 26, 587-594.
2. Akiskal HS, Benazzi F, Perugi G, Rihmer Z (2005). Agitated 'unipolar' depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Journal of Affective Disorders 85, 245-258.
3. APA (2000). Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 157, 1-45.
4. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Moller HJ (2007). World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of unipolar depressive disorders in primary care. World Journal of Biological Psychiatry 8, 67-104.
5. Beasley Jr. CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey Jr. AH, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 303, 685-692.
6. Beasley M, Reith D (2005). Deaths from poisoning in New Zealand - new study helps identify and justify priorities for prevention. New Zealand Medical Journal 118, U1723.
7. Becker DF, Grilo CM (2007). Prediction of suicidality and violence in hospitalized adolescents: comparisons by sex. Canadian Journal of Psychiatry 52, 572-580.
8. Bernal M, Haro JM, Bernert S, Brugha T, de Graaf R, Bruffaerts R, Lepine JP, de Girolamo G, Vilagut G, Gasquet I, et al. (2007). Risk factors for suicidality in Europe: results from the ESEMED study. Journal of Affective Disorders 101, 27-34.
9. Black DW, Winokur G, Mohandoss E, Woolson RF, Nasrallah A (1989). Does treatment influence mortality in depressives? A follow-up of 1076 patients with major affective disorders. Annals of Clinical Psychiatry 1, 165-173.
10. Bostwick JM, Pankratz VS (2000). Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry 157, 1925-1932.
11. Cording C, Gaebel W, Spengler A (1995). The new psychiatric basic documentation. A recommendation by the DGPPN for quality assurance in inpatient treatment [in German]. Spektrum Psychiatrie Nervenheilkunde 24, 3-41.
12. DGPPN (German Society for Psychiatry, Psychotherapy and Nervous Diseases) (2000). Practice Guidelines for the Treatment of Affective Disorders [in German]. Darmstadt: Steinkopff.
13. EMEA (2005). Note for guidance on clinical investigation of medicinal products in the treatment of depression. European Agency for Evaluation of Medicinical Products, Commitee for Proprietary Medicinal Products.
14. FDA (2007). US Food & Drug Administration. Antidepressant use in children, adolescents, and adults (http://www.fda.gov/cder/drug/antidepressants/ default.htm). Accessed 2 May 2007.
15. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 330, 396.
16. Galfalvy H, Oquendo MA, Carballo JJ, Sher L, Grunebaum MF, Burke A, Mann JJ (2006). Clinical predictors of suicidal acts after major depression in bipolar disorder: a prospective study. Bipolar Disorder 8, 586-595.
17. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ (2007). Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 164, 1356-1363.
18. Hamilton M (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278-296.
19. Hamilton MS, Opler LA (1992). Akathisia, suicidality, and fluoxetine. Journal of Clinical Psychiatry 53, 401-406.
20. Jeglic EL, Pepper CM, Vanderhoff HA, Ryabchenko KA (2007). An analysis of suicidal ideation in a college sample. Archives of Suicide Research 11, 41-56.
21. Kessler RC, Borges G, Walters EE (1999). Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Archives of General Psychiatry 56, 617-626.
22. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica 334 (Suppl.), 1-100.
23. Lipinski Jr. JF, Mallya G, Zimmerman P, Pope Jr. HG (1989). Fluoxetine-induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry 50, 339-342.
24. Moller HJ (2003). Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatrica Scandinavica 418 (Suppl.), 73-80.
25. Moller HJ (2006a). Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review. European Archives of Psychiatry and Clinical Neuroscience 256, 329-343.
26. Moller HJ (2006b). Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review. European Archives of Psychiatry and Clinical Neuroscience 256, 476-496.
27. Oquendo MA, Bongiovi-Garcia ME, Galfalvy H, Goldberg PH, Grunebaum MF, Burke AK, Mann JJ (2007). Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. American Journal of Psychiatry 164, 134-141.
28. Oquendo MA, Malone KM, Mann JJ (1997). Suicide: risk factors and prevention in refractory major depression. Depression & Anxiety 5, 202-211.
29. Posner K, Oquendo MA, Gould M, Stanley B, Davies M (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry 164, 1035-1043.
30. Qin P, Nordentoft M (2005). Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Archives of General Psychiatry 62, 427-432.
31. Renaud J, Berlim MT, McGirr A, Tousignant M, Turecki G (2008). Current psychiatric morbidity, aggression/ impulsivity, and personality dimensions in child and adolescent suicide: a case-control study. Journal of Affective Disorders 105, 221-228.
32. Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Mundt C, Holsboer F, Brieger P, Laux G, Bender W, et al. (2008). Outcomes of 1014 naturalistic treated inpatients with major depressive episode. XXVI CINP Congress, Munich, Poster Session. 13 July 2008.
33. Sokero TP, Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Isometsa ET (2003). Suicidal ideation and attempts among psychiatric patients with major depressive disorder. Journal of Clinical Psychiatry 64, 1094-1100.
34. WHO (2001). World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva: World Health Organization.
35. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M (1997). Structured Clinical Interview for DSM-IV. Göttingen: Hogrefe.
36. Witte TK, Merrill KA, Stellrecht NE, Bernert RA, Hollar DL, Schatschneider C, Joiner Jr. TE (2008). 'Impulsive' youth suicide attempters are not necessarily all that impulsive. Journal of Affective Disorders 107, 107-116.